Literature DB >> 27053879

Treatment of cancerous ascites and radical gastrectomy with intraperitoneal hyperthermic double-distilled water and cis-diaminodichloro-platinum perfusion.

Z X Chen1, J P Chen1, Z Chen1, D S Peng1, J X Zhen1, J S Tan1.   

Abstract

AIM: To study the therapeutic effect of intraperitoneal hyperthermic double-distilled water and cis-diaminodichloro-platinum (DDP) perfusion for cancerous ascites and radical gastrectomy.
METHODS: LACA mice were injected peritoneally with H22 cancer cells (2 × 10(7) tumor cells). Five days later, the mice received treatments with either intraperitoneal perfusion of 37 °C isotonic fluid (group I), or 43 °C simple hyperthermic double-distilled water (group II), isotonic fluid (group III), DDP (group IV) or a combination of the hyperthermic double-distilled water with DDP (group V). A clinical experiment with intraperitoneal hyperthermic double-distilled water perfusion with DDP was carried out from September 1991 through September 1993 with 32 advanced gastric cancer patients who had undergone radical gastrectomy.
RESULTS: In comparison with the untreated control group of cancer cell-bearing LACA mice, the mice in all treatment groups showed near complete obliteration of cancer cells in the peritoneal cavity, markedly reduced ascites, prolonged survival times, and reduced growth of peritoneal cancerous nodes. In the clinical experiment, all 32 patients with advanced carcinoma had achieved satisfactory results at the 1-year follow-up, but had unsatisfactory results at the 2-year follow-up.
CONCLUSION: The intraperitoneal hyperthermic double-distilled water perfusion with DDP inhibited the occurrence of ascites in LACA mice bearing cancer cells, and prolonged the lifetime of patients with gastric cancer who had undergone radical gastrectomy.

Entities:  

Keywords:  Ascites; Cis-diaminodichloro-platinum; Gastrectomy; Perfusion; Stomach neoplasms

Year:  1997        PMID: 27053879      PMCID: PMC4806247          DOI: 10.3748/wjg.v3.i4.246

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  6 in total

1.  Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation.

Authors:  T Fujimura; Y Yonemura; S Fushida; M Urade; S Takegawa; T Kamata; K Sugiyama; H Hasegawa; K Katayama; K Miwa
Journal:  Cancer       Date:  1990-01-01       Impact factor: 6.860

2.  Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C.

Authors:  S Koga; R Hamazoe; M Maeta; N Shimizu; A Murakami; T Wakatsuki
Journal:  Cancer       Date:  1988-01-15       Impact factor: 6.860

3.  Intraperitoneal free cancer cells and their viability in gastric cancer.

Authors:  Y Iitsuka; S Kaneshima; O Tanida; T Takeuchi; S Koga
Journal:  Cancer       Date:  1979-10       Impact factor: 6.860

4.  Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding.

Authors:  S Fujimoto; R D Shrestha; M Kokubun; M Ohta; M Takahashi; K Kobayashi; S Kiuchi; K Okui; T Miyoshi; N Arimizu
Journal:  Ann Surg       Date:  1988-07       Impact factor: 12.969

5.  Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.

Authors:  S B Howell; C E Pfeifle; W E Wung; R A Olshen
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

6.  Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer.

Authors:  N Kaibara; R Hamazoe; Y Iitsuka; M Maeta; S Koga
Journal:  Hepatogastroenterology       Date:  1989-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.